Fennec Pharmaceuticals, Inc. (FENC)

Про компанію

New Technical analysis charts - click here Financials 2014 2015 2016 more... Income Statement Revenue 0.00 0.00 0.00 Operating Income -2.88 -1.89 -2.87 Net Income -2.18 -0.66 -2.79 Basic EPS -0.22 -0.06 -0.22 Avg. Diluted Shares Outstanding 10 11 13 Balance Sheet Current Assets 2.37 1.02 3.97 Non Current Assets 0.00 0.00 0.00 Total Assets 2.37 1.02 3.97 Current Liabilities 1.76 0.47 0.40 Total Liabilities 1.76 0.47 0.40 Total Equity 0.61 0.55 3.57 Cash Flow Operating Cash Flow -1.70 -1.86 -2.12 Capital Expenditure - - - Free Cash Flow - - - In millions, except "Basic EPS". Currency is USD. Company Profile Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities.